|
Status |
Public on Sep 25, 2017 |
Title |
Tum008 |
Sample type |
RNA |
|
|
Source name |
primary tumor
|
Organism |
Mus musculus |
Characteristics |
tissue: N-Myc NCC-derived neuroblastoma
|
Growth protocol |
N-Myc transduced cells are a mixture of both p53+/- and p53-/- NCCs and are designated as N-Myc; p53mixed. At 48 hours post infection, N-Myc; p53mixed NCCs were harvested and ~10,000 cells were injected subcutaneously into nude mice or into C57Bl/6 mice After ~ 50 days primary tumors were removed from the mice
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNAs were extracted with Trizol reagent (Invitrogen) according to a supplied RNA isolation protocol.
|
Label |
Biotin (Affyexpress)
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol
|
|
|
Hybridization protocol |
Followed standard protocol for Affymetrix Mouse 2.0 ST arrays.
|
Scan protocol |
GeneChips were scanned using the GeneChip Scanner 3000 7G
|
Description |
Neuroblastoma tumor model
|
Data processing |
The data were analyzed with Partek Genomics Suite version 6.5 using the RMA method
|
|
|
Submission date |
Feb 15, 2017 |
Last update date |
Sep 25, 2017 |
Contact name |
David Finkelstein |
E-mail(s) |
david.finkelstein@stjude.org
|
Phone |
9014953931
|
Organization name |
St Jude Children's Research Hospital
|
Department |
Computational Biology
|
Street address |
332 N. Lauderdale St.
|
City |
Memphis |
State/province |
TN |
ZIP/Postal code |
38105 |
Country |
USA |
|
|
Platform ID |
GPL16570 |
Series (1) |
GSE94914 |
MYCN induces neuroblastoma in primary neural crest cells |
|